NCT03147768 - Laser Tissue Welding - Distal Pancreatectomy Sealing Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Pancreatic Tumor, BenignPancreatic NeoplasmsPancreatic AdenocarcinomaPancreatic PseudocystPancreatic Neuroendocrine TumorPancreas; InsulinomaPancreatic CystPancreatic TeratomaPancreatic Polypeptide TumorPancreatic VipomaPancreatic CystadenomaPancreas InjuryPancreatic GastrinomaPancreatic Glucagonoma

Interventions

DEVICE

Distal Pancreatectomy Sealing Using LTW

The device's intended use is to seal the pancreatic surface using a laser to weld human albumin based biomaterials after surgical removal of pancreatic tumors during a partial pancreatectomy.

Trial Locations (1)

77030

Baylor CHI St. Luke's Medical Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

CHI St. Luke's Health, Texas

OTHER

lead

Laser Tissue Welding, Inc.

INDUSTRY